The Asia-Pacific medicated confectionery market is expected to reach USD 2,757 million by 2023 witnessing a fastest CAGR during the forecast period. The Asia-Pacific medicated confectionery sale has surpassed 101 million Kg in 2017. The Asia-Pacific Medicated Confectionery market grew from 92.6 million Kg in 2013 to 104.5 million Kg in 2018 registering a volume CAGR of 2.5%, during the historic period.
The scope of the market includes sugar confectionery containing herbs and/or plants extracts, cough drops, lozenges, and all other sugar confectionery products that make health claims e.g. Halls. Asia-Pacific is the most significant market holding a market share of 34% in 2017 mainly driven by India and China. China is the fastest growing Medicated Confectionery market witnessing a value CAGR of 5.2%, during the forecast period. Expanding retail distribution, such as supermarkets/hypermarkets, remains the key driver for the region.
Rising health concern among consumers for confectionery products has increased the demand for herbs and active ingredients into products. Medicated confectionery containing active ingredients, such as antacids, vitamins, and herbal extracts are used to prevent such cases, thus, driving sales. Herbs, such as guarana, ginsengs imparts energy while extracts, such as green tea, superfruits provide antioxidants that boosts immune. The demand for antioxidants is growing owing to its health benefits in herbal confectionery market. Acerola and ginseng are the most consumed active ingredients used in the product, which is followed by green tea extracts. Growing adoption of western lifestyle is giving rise to allergic rhinitis in the countries. The cases of hay fever, asthma and allergen are more prominent in developing region as compared to developed countries. Herbal confectionery is gaining attraction due to natural and organic nature and its health claim. Medicated confectionery infused with herbs are continue to grow at a faster pace. However, vitamin fortified confectionery sale is expected to dominate in future as well, owing to cheap price and bulk volume demand.
China dominates the medicated confectionery market in Asia-Pacific, which is followed by Japan. Asia-Pacific medicated confectionery market size around 101 million Kg in 2017, which is growing at a faster rate. Rising higher living standard and awareness are driving consumer towards better confectionery products. Increased average consumer spending on small packaged confectionery that are price-sensitive is further supporting the market growth. Despite of the economic slowdown on consumer goods in China, medicated confectionery has performed well. Increased demand for herbal infused products due to its health benefit is driving the market. Medicated confectionery has high demand mainly during winters due to increased influence of cold and cough.
The Asia-Pacific medicated confectionery market is competitive with large number of domestic and multinational player competing for market share. Acquisition and product innovation claiming sugar-free is the main strategy adopted by players.
Major players include- Nestlé S.A, Mondelēz International, Inc., Procter & Gamble Co., Perfetti Van Melle, Reckitt Benckiser Group plc, Ricola Ltd., among others.
1.1 Key Deliverables of the Study
1.2 Study Assumptions
1.3 Scope of the Market
2. Research Approach and Methodology
2.2 Research Design
2.3 Study Timelines
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering and Econometric Modeling
2.4.4 Expert Validation
3. Market Overview
3.1 Market Trends
3.2 Market Dynamics
18.104.22.168 Consumers Seeking Relief from Hay-fever and Other Cold-related Issues
22.214.171.124 Ban on Smoking in Public Places and Reduced Number of Smokers in Japan
126.96.36.199 Consumer Demands for Mint
188.8.131.52 Growing Consumer Demand for Active Ingredients In Confectionery
3.2.4 Porter's Five Forces Analysis
184.108.40.206 Bargaining Power of Suppliers
220.127.116.11 Bargaining Power of Buyers
18.104.22.168 Threat of New Entrants
22.214.171.124 Threat of Substitute Products and Services
126.96.36.199 Degree of Competition
4. Market Segmentation
4.1 By Distribution Channel
4.1.1 Convenience Stores
4.1.2 Specialist Retailers
4.1.3 Supermarkets and Hypermarkets
4.1.4 Online Retail
4.1.5 Variety Stores
4.1.6 Department Stores
4.2 By Geography
188.8.131.52 Rest of Asia-Pacific
5. Competitive Landscape
5.1 Market Share Analysis
5.2 Strategy Adopted by Key Players
5.3 Most Active Companies in the Past Five Years
6. List of Company Profiles
6.2 Products & Services
6.4 Key Developments
6.5 Strategies Adopted
6.6 SWOT Analysis of Major Five Players
7. Companies Covered
7.1 Mondelēz International, Inc.
7.2 Nestlé SA
7.3 Procter & Gamble Co.
7.4 Perfetti Van Melle
7.5 Reckitt Benckiser Group Plc
7.6 Ricola Ltd
7.7 Wm. Wrigley Jr. Company
7.8 Herbion International Inc.
7.9 The Hershey Company
7.10 Mars, Incorporated
LIST OF TABLES
1: Medicated Confectionery Market: Revenue in USD million, by Country, Asia-Pacific, 2015-2023
2: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, Asia-Pacific, 2015-2023
3: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, India, 2015-2023
4: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, China, 2015-2023
5: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, Australia, 2015-2023
6: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, Japan, 2015-2023
7: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, Rest of Asia-Pacific, 2015-2023
8: Medicated Confectionery Market: Revenue in USD million, by Distribution Channel, Asia-Pacific, 2015-2023
9: Medicated Confectionery Market: Volume in million Kg, by Country, Asia-Pacific, 2015-2023